IP Library Granted Patent US 10,357,564
Granted Patent B2
US 10,357,564 · App. 15/458,685 · Granted Jul 23, 2019

Virus-PCION complex having enhanced antitumor effect by using electromagnetic field

Inventors: Chae Ok Yun (Seoul, KR); Joung-Woo Choi (Seoul, KR)
Assignee: INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY
A61K41/00A61K9/5146A61K9/5169A61K41/0052A61K47/60A61K47/645A61K47/6923A61K47/6941C12N7/00C12N15/86A61K35/761C12N2710/10332C12N2710/10343
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,357,564
App. No.
15/458,685
Granted
Jul 23, 2019
Kind
B2
Abstract

The present disclosure relates to a composition for transduction of a virus in a cell by using a crosslinked product of PEGylated magnetic nanoparticles and catechol grafted poly-L-lysine by application of an external magnetic field. When the composition is used, a virus may be delivered into cells more rapidly and efficiently than in intracellular uptake of a virus by CAR-mediated endocytosis.

Claims (7)

1. A method of enhancing transduction efficiency of a virus in a cell, the method comprising:

administering, to an individual, a complex comprising: (a) magnetic nanoparticles cross-linked with catechol grafted poly-L-lysine and having PEGylated surfaces; and (b) a virus; and

applying an external magnetic field (MGF) to the complex-administered individual

wherein a molar ratio of the magnetic nanoparticles to the virus in the complex ranges from about 1:2×10 6 to about 1:5×10 7 .

2. The method of claim 1 , wherein the magnetic nanoparticles comprise one selected from the group consisting of maghemite (Fe 2 O 3 ), magnetite (Fe 3 O 4 ), and mixtures thereof.

3. The method of claim 1 , wherein in the catechol grafted poly-L-lysine, a degree of substitution of a catechol functional group with respect to the poly-L-lysine ranges from about 5 to about 30.

4. The method of claim 1 , wherein a weight ration of the magnetic nanoparticles and the catechol grafted poly-L-lysine is about 10:1 to about 1:5.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2020
From: INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY
To: GENEMEDICINE CO., LTD.
Reel/Frame 052511/0457 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2017
From: YUN, CHAE OK; CHOI, JOUNG-WOO
To: INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY
Reel/Frame 041623/0507 →
Priority Claims (1)
KR 10-2016-0030514 · Mar 14, 2016 · national
Continuity (1)
Related Publication 20170258906A1 · Sep 14, 2017